Phibro Animal Health Corp - Class A
Research Phibro Animal Health Corp - Class A (PAHC) on Bullrun: valuation model: 15.8% undervalued, market cap USD 1.46B, P/E 15.4, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPAHC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Valuation signal15.8% undervalued
- Market capUSD 1.46B
- P/E15.4
- Dividend yield1.3%
- Financial periodQ1 2026
- RevenueUSD 383.54M
- Net incomeUSD 24.02M
- Free cash flowUSD 12.77M
- Gross margin32.8%
Valuation Snapshot
Bullrun's latest valuation model marks Phibro Animal Health Corp - Class A as 15.8% undervalued; latest market cap is USD 1.46B; P/E is 15.4; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 15.43x versus a Healthcare sector median of 24.46x (36.9% below).
Latest dividend yield is 1.32% versus a Healthcare sector median of 2.11% (37.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.30B | USD 48.26M | USD 41.83M | 30.9% | 1.19 | USD 68.04M | USD 631.69M | USD 285.68M |
| FY2024 | USD 1.02B | USD 2.42M | USD 46.36M | 30.8% | 0.06 | USD 70.61M | USD 312.08M | USD 256.64M |
| FY2023 | USD 977.89M | USD 32.61M | -USD 38.48M | 30.5% | 0.81 | USD 41.28M | USD 333.84M | USD 282.51M |
| FY2022 | USD 942.26M | USD 49.18M | -USD 5.40M | 30.3% | 1.21 | USD 74.25M | USD 287.93M | USD 262.44M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.46B | 15.4 | 1.3% | 0.48 |
| 2025 | 2025-12-31 | USD 1.51B | 16.5 | 1.3% | 0.48 |
| 2024 | 2024-12-31 | USD 850.58M | 43.8 | 2.3% | 0.48 |
| 2023 | 2023-12-29 | USD 469.03M | 22.7 | 4.1% | 0.48 |
| 2022 | 2022-12-30 | USD 543.15M | 11.7 | 3.6% | 0.48 |
| 2021 | 2021-12-31 | USD 827.08M | 15.6 | 2.4% | 0.48 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.48 USD, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.48 USD |
| FY2024 | 0.48 USD |
| FY2023 | 0.48 USD |
| FY2022 | 0.48 USD |
About Phibro Animal Health Corp - Class A
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Phibro Animal Health Corp - Class A overvalued or undervalued?
Bullrun's valuation model currently marks Phibro Animal Health Corp - Class A as 15.8% undervalued.
What is Phibro Animal Health Corp - Class A's market cap?
Phibro Animal Health Corp - Class A's market capitalization is USD 1.46B.
What is Phibro Animal Health Corp - Class A's P/E ratio?
Phibro Animal Health Corp - Class A's price-to-earnings (P/E) ratio is 15.4.
Does Phibro Animal Health Corp - Class A pay a dividend?
Phibro Animal Health Corp - Class A has a dividend yield of 1.3%.
What does Phibro Animal Health Corp - Class A do?
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.